Given that miR146a expression is increased in IBD patients [8,74] and in our model of colitis, it is likely that the physiological rise in miR146a in response to NF-kB activation is insufficient in counteracting the overactivation of multiple inflammatory signaling pathways. Here, NFKB1 is linked to inflammatory bowel disease.